Skip to main content
Erschienen in: Journal of Clinical Immunology 4/2013

01.05.2013 | Original Research

Tumor Necrosis Factor Receptor-associated Factor 1 influences KRN/I-Ag7 Mouse Arthritis Autoantibody Production

verfasst von: Tao Cheng, Yongwon Choi, Terri H. Finkel, Patricia Y. Tsao, Mei Qing Ji, Robert A. Eisenberg

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Recently, genomewide association analysis has revealed that the Tumor Necrosis Factor Receptor-associated factor 1-Complement 5 (TRAF1-C5) containing locus on chromosome 9 was associated with an increased risk for RA. Studies in model systems suggested that either gain- or loss-of-function TRAF1 mutations have immune effects that could plausibly lead to or exacerbate the arthritis phenotype. KRN/I-Ag7 (KxB/N) is a genetic mouse model of inflammatory arthritis. We aimed to assess the impact of TRAF1 deficiency on KRN/I-Ag7 mice.

Methods

We have bred KRN/I-Ag7 mice onto a TRAF1-deficient background and followed cohorts for the spontaneous appearance of arthritis. We have also transferred KxB/N serum to B6.I-Ag7 TRAF1KO recipients. In addition, systemic autoimmunity was induced through cGVH by injecting bm12 splenocytes into TRAF1KO recipient mice.

Results

TRAF1-deficient KRN/I-Ag7 mice spontaneously developed severe, progressive arthritis, comparable to that seen in TRAF1-intact KRN/I-Ag7 mice. However, the anti-GPI antibody titer was significantly lower in the former group. Interestingly, the TRAF1KO mice that had background levels of anti-GPI antibodies still showed severe arthritis, although with a brief delay compared to TRAF1 sufficient mice. In addition, TRAF1KO mice were fully susceptible to passive, serum transfer experiments. In another model of autoimmunity, TRAF1KO had no effect on cGVH autoantibodies production; nor was the response to an exogenous antigen impaired.

Conclusion

The pathogenesis of spontaneous KRN/I-Ag7 arthritis can largely proceed by TRAF1-independent pathways. The production of anti-GPI autoantibody, but not other autoantibody or antibody responses, was markedly impaired by TRAF1 deficiency. The spontaneous arthritis model in KRN mice appears to be much less antibody dependent than previously believed.
Literatur
2.
Zurück zum Zitat Newton JL, Harney SM, Wordsworth BP, Brown MA. A review of the MHC genetics of rheumatoid arthritis. Genes Immun. 2004;5:151.PubMedCrossRef Newton JL, Harney SM, Wordsworth BP, Brown MA. A review of the MHC genetics of rheumatoid arthritis. Genes Immun. 2004;5:151.PubMedCrossRef
3.
Zurück zum Zitat Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005;77:1044–60.PubMedCrossRef Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005;77:1044–60.PubMedCrossRef
4.
Zurück zum Zitat Lee AT, Li W, Liew A, Bombardier C, Weisman M, Massarotti EM, et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun. 2005;6:129–33.PubMedCrossRef Lee AT, Li W, Liew A, Bombardier C, Weisman M, Massarotti EM, et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun. 2005;6:129–33.PubMedCrossRef
5.
Zurück zum Zitat Maini RN. Current and new antitumor necrosis factor agents in perspective. Arthritis Res Ther. 2004;6:S1–2.PubMedCrossRef Maini RN. Current and new antitumor necrosis factor agents in perspective. Arthritis Res Ther. 2004;6:S1–2.PubMedCrossRef
6.
Zurück zum Zitat Kurreeman FAS, Padyukov L, Marques RB, et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med. 2007;4:e278.PubMedCrossRef Kurreeman FAS, Padyukov L, Marques RB, et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med. 2007;4:e278.PubMedCrossRef
7.
Zurück zum Zitat Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis- a genomewide study. N Engl J Med. 2007;357:1199.PubMedCrossRef Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis- a genomewide study. N Engl J Med. 2007;357:1199.PubMedCrossRef
8.
Zurück zum Zitat Arch RH, Gedrich RW, Thompson CB. Tumor necrosis factor receptor-associated factors (TRAFs)-α family of adapter proteins that regulates life and death. Gene Dev. 1998;12:2821–30.PubMedCrossRef Arch RH, Gedrich RW, Thompson CB. Tumor necrosis factor receptor-associated factors (TRAFs)-α family of adapter proteins that regulates life and death. Gene Dev. 1998;12:2821–30.PubMedCrossRef
9.
Zurück zum Zitat Fotin-Mleczek M, Henkler F, Hausser A, Glauner H, Samel D, Graness A, et al. TRAF1 regulates CD40-induced TRAF2-mediated NF-κB activation. J Biol Chem. 2004;279:677–85.PubMedCrossRef Fotin-Mleczek M, Henkler F, Hausser A, Glauner H, Samel D, Graness A, et al. TRAF1 regulates CD40-induced TRAF2-mediated NF-κB activation. J Biol Chem. 2004;279:677–85.PubMedCrossRef
10.
Zurück zum Zitat Kato Jr T, Gotoh Y, Hoffmann A, Ono Y. Negative regulation of constitutive NF-κB and JNK signaling by PKN1-mediated phosphorylation of TRAF1. Genes to Cells. 2008;13:509–20.PubMedCrossRef Kato Jr T, Gotoh Y, Hoffmann A, Ono Y. Negative regulation of constitutive NF-κB and JNK signaling by PKN1-mediated phosphorylation of TRAF1. Genes to Cells. 2008;13:509–20.PubMedCrossRef
11.
Zurück zum Zitat Lavorgna A, De Filippi R, Formisano S, Leonardi A. TNF receptor-associated factor 1 is a positive regulator of the NF-κB alternative pathway. Mol Immunol. 2009;46:3278–82.PubMedCrossRef Lavorgna A, De Filippi R, Formisano S, Leonardi A. TNF receptor-associated factor 1 is a positive regulator of the NF-κB alternative pathway. Mol Immunol. 2009;46:3278–82.PubMedCrossRef
12.
Zurück zum Zitat Sabbagh L, Srokowski CC, Pulle G, Snell LM, Sedgmen BJ, Liu Y, et al. A critical role for TNF receptor-associated factor 1 and Bimdown-regulation in CD8 memory T cell survival. Proc Natl Acad Sci U S A. 2006;103:18703–8.PubMedCrossRef Sabbagh L, Srokowski CC, Pulle G, Snell LM, Sedgmen BJ, Liu Y, et al. A critical role for TNF receptor-associated factor 1 and Bimdown-regulation in CD8 memory T cell survival. Proc Natl Acad Sci U S A. 2006;103:18703–8.PubMedCrossRef
13.
Zurück zum Zitat Wicovsky A, Henkler F, Salzmann S, Scheurich P, Kneitz C, Wajant H. Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling andmodifies TNFR1-TNFR2 cooperation. Oncogene. 2009;28:1769–81.PubMedCrossRef Wicovsky A, Henkler F, Salzmann S, Scheurich P, Kneitz C, Wajant H. Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling andmodifies TNFR1-TNFR2 cooperation. Oncogene. 2009;28:1769–81.PubMedCrossRef
14.
Zurück zum Zitat Asquith DL, Miller AM, McInnes IB, Liew FY. Animal models of rheumatoid arthritis. Eur J Immunol. 2009;39:2040–4.PubMedCrossRef Asquith DL, Miller AM, McInnes IB, Liew FY. Animal models of rheumatoid arthritis. Eur J Immunol. 2009;39:2040–4.PubMedCrossRef
15.
Zurück zum Zitat Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell. 1996;87:811–22.PubMedCrossRef Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell. 1996;87:811–22.PubMedCrossRef
16.
Zurück zum Zitat Matsumoto I, Staub A, Benoist C, Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science. 1999;286:1732–5.PubMedCrossRef Matsumoto I, Staub A, Benoist C, Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science. 1999;286:1732–5.PubMedCrossRef
17.
Zurück zum Zitat Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 1999;10:451–61.PubMedCrossRef Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 1999;10:451–61.PubMedCrossRef
18.
Zurück zum Zitat Hong J, Koichiro O, Mahmood U, Lee DM, Hofhuis FMA, Boackle SA, et al. Arthritis critically dependent on innate immune system players. Immunity. 2002;16:157–68.CrossRef Hong J, Koichiro O, Mahmood U, Lee DM, Hofhuis FMA, Boackle SA, et al. Arthritis critically dependent on innate immune system players. Immunity. 2002;16:157–68.CrossRef
19.
Zurück zum Zitat Binstadt BA, Hebert JL, Ortiz-Lopez A, Bronson R, Benoist C, Mathis D. The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms. Proc Natl Acad Sci U S A. 2009;106:16758–63.PubMedCrossRef Binstadt BA, Hebert JL, Ortiz-Lopez A, Bronson R, Benoist C, Mathis D. The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms. Proc Natl Acad Sci U S A. 2009;106:16758–63.PubMedCrossRef
20.
Zurück zum Zitat Tsao PY, Arora V, Ji MQ, Wright AC, Eisenberg RA. KRN/I-Ag7 mouse arthritis is independent of complement C3. J Clin Immunol. 2011;31:857–63.PubMedCrossRef Tsao PY, Arora V, Ji MQ, Wright AC, Eisenberg RA. KRN/I-Ag7 mouse arthritis is independent of complement C3. J Clin Immunol. 2011;31:857–63.PubMedCrossRef
21.
Zurück zum Zitat Monach PA, Mathis D, Benoist C. The K/BxN arthritis model. In: Coligan JE et al., editors. Current protocols in immunology, Chapter 15: Unit 15 22. New York: Wiley; 2008. Monach PA, Mathis D, Benoist C. The K/BxN arthritis model. In: Coligan JE et al., editors. Current protocols in immunology, Chapter 15: Unit 15 22. New York: Wiley; 2008.
22.
Zurück zum Zitat Tsao PY, Jiao J, Ji MQ, Cohen PL, Eisenberg RA. T cell-independent spontaneous loss of tolerance by anti-double-stranded DNA B cells in C57BL/6 mice. J Immunol. 2008;181:7770–7.PubMed Tsao PY, Jiao J, Ji MQ, Cohen PL, Eisenberg RA. T cell-independent spontaneous loss of tolerance by anti-double-stranded DNA B cells in C57BL/6 mice. J Immunol. 2008;181:7770–7.PubMed
23.
Zurück zum Zitat Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein anti-gen induces localized allergic dermatitis and hyperresponsiveness tomethacholine after single exposure to aerosolized antigen inmice. J Clin Investig. 1998;101:1614–22.PubMedCrossRef Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein anti-gen induces localized allergic dermatitis and hyperresponsiveness tomethacholine after single exposure to aerosolized antigen inmice. J Clin Investig. 1998;101:1614–22.PubMedCrossRef
24.
Zurück zum Zitat Feuerstein N, Chen F, Madaio M, Maldonado M, Eisenberg RA. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. J Immunol. 1999;163:5287–97.PubMed Feuerstein N, Chen F, Madaio M, Maldonado M, Eisenberg RA. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. J Immunol. 1999;163:5287–97.PubMed
25.
Zurück zum Zitat Xavier RJ, Rioux JD. Genome-wide association studies: a new window into immune-mediated diseases. Nat Rev Immunol. 2008;8:631–43.PubMedCrossRef Xavier RJ, Rioux JD. Genome-wide association studies: a new window into immune-mediated diseases. Nat Rev Immunol. 2008;8:631–43.PubMedCrossRef
26.
Zurück zum Zitat Tsitsikov EN, Laouini D, Dunn IF, Sannikova TY, Davidson L, Alt FW, et al. TRAF1 Is a Negative Regulator of TNF Signaling: Enhanced TNF Signaling in TRAF1-Deficient Mice. Immunity. 2001;15:647–57.PubMedCrossRef Tsitsikov EN, Laouini D, Dunn IF, Sannikova TY, Davidson L, Alt FW, et al. TRAF1 Is a Negative Regulator of TNF Signaling: Enhanced TNF Signaling in TRAF1-Deficient Mice. Immunity. 2001;15:647–57.PubMedCrossRef
27.
Zurück zum Zitat Kyburz D, Corr M. The KRN mouse model of inflammatory arthritis. Springer Semin Immun. 2003;25:79–90.CrossRef Kyburz D, Corr M. The KRN mouse model of inflammatory arthritis. Springer Semin Immun. 2003;25:79–90.CrossRef
28.
Zurück zum Zitat Jacobs JP, Wu HJ, Benoist C, Mathis D. IL-17-producing T cells can augment autoantibody-induced arthritis. Proc Natl Acad Sci U S A. 2009;106:21789–94.PubMedCrossRef Jacobs JP, Wu HJ, Benoist C, Mathis D. IL-17-producing T cells can augment autoantibody-induced arthritis. Proc Natl Acad Sci U S A. 2009;106:21789–94.PubMedCrossRef
29.
Zurück zum Zitat Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32:815–27.PubMedCrossRef Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32:815–27.PubMedCrossRef
30.
Zurück zum Zitat Schellekens GA, Visser H, De Jong BAW, van den Hoogen FHJ, Hazes JMW, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43:155–63.PubMedCrossRef Schellekens GA, Visser H, De Jong BAW, van den Hoogen FHJ, Hazes JMW, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43:155–63.PubMedCrossRef
Metadaten
Titel
Tumor Necrosis Factor Receptor-associated Factor 1 influences KRN/I-Ag7 Mouse Arthritis Autoantibody Production
verfasst von
Tao Cheng
Yongwon Choi
Terri H. Finkel
Patricia Y. Tsao
Mei Qing Ji
Robert A. Eisenberg
Publikationsdatum
01.05.2013
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 4/2013
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-013-9866-5

Weitere Artikel der Ausgabe 4/2013

Journal of Clinical Immunology 4/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.